Medtronic company said it has received U.S. Food and Drug Administration 510(k) clearance for and plans to launch its OsteoCool RF Ablation System in the U.S. The OsteoCool System is the only cooled radiofrequency ablation technology that offers simultaneous, dual-probe capabilities - providing procedural flexibility and predictable, customized treatment. Cooled RF ablation uses targeted high-frequency energy to destroy cancer cells.